Should Colorectal Cancer Patients be Followed After Five Years? Study of Recurrence in a Population Cohort

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01904955

Enrollment

598

Registered

2013-07-22

Start date

2010-09-01

Completion date

Unknown

Last updated

2026-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Brief summary

The results of this study will make it possible, thanks to better understanding of the natural history of colorectal cancer, to define new treatment and surveillance strategies for colorectal cancers resected with curative intent, so as to improve management and thus improve patient survival. These data will also make it possible to calculate the prevalence of patients who require treatment or surveillance because of their disease.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* with adenocarcinoma of the colon or rectum (ICD-O: C18, C19 and C20) * residing in the département of Côte-d'Or (501,000 inhabitants according to the 1999 census) or Calvados (511, 012 inhabitants) at the moment of diagnosis * recorded by either Registry between January 1985 and December 2000 * treated by resection with a curative intent.

Exclusion criteria

Will be excluded other morphologic tumours and initially metastatic colorectal cancers, anal cancers.

Design outcomes

Primary

Measure	Time frame	Description
data concerning evolving relapse	during the 10 years following resection for colorectal cancer with curative intent	* the date of recurrence * the site * the finality of the surgical treatment (resection with curative intent defined as macroscopically complete resection, without involvement of the surgical margin in the histological examination) * the non-surgical adjuvant or palliative treatments (radiotherapy, chemotherapy).

Countries

France

Contacts

PRINCIPAL_INVESTIGATORFAIVRE Jean

CHU Dijon Gastroentérologie

Outcome results